NUS1 and Parkinson disease: Longitudinal analyses showed similar progression rates of UPDRS III and H&Y stage (off‐medication) in NUS1‐PD and GU‐PD, but a slower progression rate of urinary function in NUS1‐PD (p = 0.024).